Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis
Clinical trial NCT02376972 · TERMINATED
Trial details
- NCT number
- NCT02376972
- Sponsor
- Alfasigma S.p.A.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2016-02-01
- Enrollment
- 392
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.